The chronic care for age-related macular degeneration study (CHARMED): Study protocol for a randomized controlled trial

BACKGROUND: Neovascular age-related macular degeneration is the leading cause of irreversible blindness in people 50 years of age or older in the developed world. As in other chronic diseases, several effective treatments are available, but in clinical daily practice there is an evidence performance...

Descripción completa

Detalles Bibliográficos
Autores principales: Frei, Anja, Woitzek, Katja, Wang, Mathyas, Held, Ulrike, Rosemann, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214138/
https://www.ncbi.nlm.nih.gov/pubmed/21985296
http://dx.doi.org/10.1186/1745-6215-12-221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214138/
https://www.ncbi.nlm.nih.gov/pubmed/21985296
http://dx.doi.org/10.1186/1745-6215-12-221

Ejemplares similares